Literature DB >> 8245075

Avascular necrosis of the femoral head in sickle-cell disease. Treatment of collapse by the injection of acrylic cement.

P Hernigou1, D Bachir, F Galacteros.   

Abstract

In ten patients with sickle-cell disease, we used a new technique of cement injection for the treatment of 16 painful hips with a radiographic crescent line or flattening of the articular surface due to avascular necrosis. The necrotic bone and overlying cartilage are elevated by the injection to restore the sphericity of the femoral head. Five days after the operation, full weight-bearing was allowed with the help of crutches for three weeks. The time in hospital averaged eight days; the average blood loss was 100 ml. There was early pain relief and postoperative radiographs showed improvement in the shape of the femoral head. At a mean follow-up of 5 years (3 to 7), 14 of the 16 hips were still improved although some gave slight pain. Only two hips had required revision to total hip arthroplasty, at one year and two years respectively. The increasing longevity of patients with sickle-cell disease means that avascular necrosis will be an increasing problem. Total hip replacement has a poor prognosis because of the risks of infection, high blood loss, and early loosening. Cement injection does not have these problems and allows for earlier, more conservative surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245075

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  8 in total

1.  Open reduction and cementation for femoral head fracture secondary to avascular necrosis: preliminary report.

Authors:  M L Wood; C M McDowell; T L Kerstetter; S S Kelley
Journal:  Iowa Orthop J       Date:  2000

2.  Inefficacy of the cementation of femoral head collapse in glucocorticoid-induced osteonecrosis.

Authors:  Valérie Gangji; Marcel Rooze; Viviane De Maertelaer; Jean-Philippe Hauzeur
Journal:  Int Orthop       Date:  2008-02-23       Impact factor: 3.075

3.  Total THA in adult osteonecrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Sebastien Zilber; Paolo Filippini; Gilles Mathieu; Alexandre Poignard; Frederic Galacteros
Journal:  Clin Orthop Relat Res       Date:  2008-01-10       Impact factor: 4.176

4.  Treatment for avascular necrosis of bone in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Luis H Agreda-Pérez
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

Review 5.  Musculoskeletal Manifestations of Sickle Cell Disease: A Review.

Authors:  Raju Vaishya; Amit Kumar Agarwal; Edwin O Edomwonyi; Vipul Vijay
Journal:  Cureus       Date:  2015-10-20

6.  Avascular Necrosis of Femoral Head: A Metabolomic, Biophysical, Biochemical, Electron Microscopic and Histopathological Characterization.

Authors:  Aswath Narayanan; Prakash Khanchandani; Roshan M Borkar; Chandrashekar Reddy Ambati; Arun Roy; Xu Han; Ritesh N Bhoskar; Srinivas Ragampeta; Francis Gannon; Vijaya Mysorekar; Balasubramanyam Karanam; Sai Muthukumar V; Venketesh Sivaramakrishnan
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

Review 7.  Hypoxia-inducible factor (HIF): how to improve osseointegration in hip arthroplasty secondary to avascular necrosis in sickle cell disease.

Authors:  Akintunde George; Marianne Ellis; Harinderjit Singh Gill
Journal:  EFORT Open Rev       Date:  2019-09-10

8.  Sickle cell disease: management options and challenges in developing countries.

Authors:  Daniel Ansong; Alex Osei Akoto; Delaena Ocloo; Kwaku Ohene-Frempong
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.